Human Platelet Lysate Market Report
Human Platelet Lysate Market, By Type (Heparin-free Platelet Lysates, Human Platelet Lysates with Heparin), By Application (Research Use, Clinical Use), By End User (Academic and Research Institutes, Biopharmaceutical Companies, Others) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global human platelet lysate market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Human Platelet Lysate Market, By Type (Heparin-free Platelet Lysates, Human Platelet Lysates with Heparin), By Application (Research Use, Clinical Use), By End User (Academic and Research Institutes, Biopharmaceutical Companies, Others) and Region ...
Impact of COVID-19 on Human Platelet Lysate Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Human Platelet Lysate Market is estimated to grow from USD 48.2 million in 2020 to USD 59.8 million by 2026 at a healthy CAGR of 3.7% during the forecast period.
Human Platelet Lysate (HPL) is a non-animal derived cell culture growth supplement which is obtained from blood platelets after freezing and thawing. It contains abundant factors and cytokines required for cell growth and proliferation. Platelet lysate can be utilized as a source of growth for replacing bovine serum in a cell culture medium.
Key players operating in the human platelet lysate market are-
Growing emphasis on funding & rise in research centers, government regulations, clinical and staff efficiency, product innovation, and user acceptance are some of the key driving factors propelling the growth of the human platelet lysate market during the review period. Also, rising awareness levels of blood donation coupled with increasing adoption of advanced blood collection & processing technology in developing countries is also anticipated to augment the human platelet lysate market growth.
Based on application, the market has been bifurcated into research use and clinical use. The research use segment accounted for a substantial market share in 2020. The evolution of human platelet lysates has bolstered various experimental and clinical research studies. Also, growing government funding for life science-related projects and an increasing number of research centers and research institutes boost the segment growth.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure and favorable government initiatives. Moreover, rising innovations in technologically advanced products, immense per capita health expenditures, increasing numbers of chronic patients, which further proliferate the regional growth.
The COVID-19 outbreak moderately affected the growth of the human platelet lysate market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. As the medical community is treating the infected patients, the research related to human platelet lysate was moderately impacted, thus resulting in fewer visits to clinics.
Here is the list of the group of customers that the human platelet lysate market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.
The human platelet lysate market is expected to witness an impressive growth of 3.7% CAGR in the coming years.
Merck KGaA (Germany), Compass Biomedical Inc. (US), Macopharma SA (France), Mill Creek Life Sciences Llc., Stemcell Technologies Inc. (Canada), Zen-Bio, Inc., Sclavo Diagnostics Interna-tional Srl. (Italy), Life Science Group Limited (Life Science Production) (India), and Trinova Bio-chem Gmbh (Germany) are among the key players in the human platelet lysate market.
The human platelet lysate market size is expected to reach USD 59.8 million in the foreseeable future.
The research use segment accounted for a substantial share in the human platelet lysate market in 2020.
North America is expected to remain dominant in the human platelet lysate market in the next five years.
Human Platelet Lysate distributors, Human Platelet Lysate suppliers, Human Platelet Lysate manufacturers, Hospitals, Government bodies are the target audience in the human platelet lysate market.